Surya Fajar Capital Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Surya Fajar Capital Tbk. trades at Rp1,950 (market cap 2.67T, 31.6K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.4× Surya Fajar Capital Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 31.6K). Which is the better fit depends on your goals.
| SFAN | TSPC | |
|---|---|---|
Market Cap | 2.67T | 11.68T |
Volume | 31.6K | 429.7K |
Lot | 316 | 4.3K |
Turnover | 61.56M | 1.11B |
Average Price | 1,947.94 | 2,591.65 |
Value | 61.56M | 1.11B |
Indicative Equilibrium Price | — | 2,580 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.
Read more on SFAN →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →